Nablus Surgical Center Company PLC

PLSE:NSC Stock Report

Market Cap: د.أ10.0m

Nablus Surgical Center Valuation

Is NSC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NSC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NSC (JOD2.95) is trading above our estimate of fair value (JOD0.34)

Significantly Below Fair Value: NSC is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NSC?

Key metric: As NSC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for NSC. This is calculated by dividing NSC's market cap by their current revenue.
What is NSC's PS Ratio?
PS Ratio2x
Salesد.أ4.99m
Market Capد.أ10.03m

Price to Sales Ratio vs Peers

How does NSC's PS Ratio compare to its peers?

The above table shows the PS ratio for NSC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.4x
SPMD Speed Medical Co
11.7xn/aج.م625.6m
9220 FB Care ServiceLtd
0.2xn/aJP¥2.5b
IBNH Ibn-Alhaytham Hospital Co (P.S.C)
1.1xn/aد.أ13.0m
6545 internet infinity
0.5x4.2%JP¥2.7b
NSC Nablus Surgical Center
2xn/aد.أ10.0m

Price-To-Sales vs Peers: NSC is good value based on its Price-To-Sales Ratio (2x) compared to the peer average (3.4x).

Price to Sales Ratio vs Industry

How does NSC's PS Ratio compare vs other companies in the Asian Healthcare Industry?

62 CompaniesPrice / SalesEstimated GrowthMarket Cap
NSC 2.0xIndustry Avg. 1.6xNo. of Companies64PS01.63.24.86.48+
62 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: NSC is expensive based on its Price-To-Sales Ratio (2x) compared to the Asian Healthcare industry average (1.6x).

Price to Sales Ratio vs Fair Ratio

What is NSC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NSC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate NSC's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies